DarioHealth Corp. Research And Development Expense

Quick Answer

DarioHealth Corp. reported Research And Development Expense of $13.79 million for the year ending 2025.

  • DarioHealth Corp. showed a decrease of -43.0% in Research And Development Expense from 2024 to 2025.
  • This data is from DarioHealth Corp.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
  • XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2013: $1.42 million | Q3 2013: $1.08 million | Q1 2014: $1.11 million | Q2 2014: $1.33 million | Q3 2014: $769.0 thousand | Q1 2015: $883.0 thousand | Q2 2015: $441.0 thousand | Q3 2015: $667.0 thousand | Q1 2016: $397.0 thousand | Q2 2016: $521.0 thousand | Q3 2016: $659.0 thousand | Q1 2017: $469.0 thousand | Q2 2017: $1.18 million | Q3 2017: $797.0 thousand | Q1 2018: $742.0 thousand | Q2 2018: $1.01 million | Q3 2018: $997.0 thousand | Q1 2019: $1.00 million | Q2 2019: $991.0 thousand | Q3 2019: $859.0 thousand | Q1 2020: $1.23 million | Q2 2020: $825.0 thousand | Q3 2020: $954.0 thousand | Q1 2021: $2.66 million | Q2 2021: $3.74 million | Q3 2021: $5.51 million | Q1 2022: $5.93 million | Q2 2022: $4.14 million | Q3 2022: $4.80 million | Q1 2023: $5.17 million | Q2 2023: $5.22 million | Q3 2023: $5.67 million | Q1 2024: $6.64 million | Q2 2024: $6.81 million | Q3 2024: $5.45 million | Q1 2025: $4.11 million | Q2 2025: $3.72 million | Q3 2025: $3.33 million.
  • Over the full 14 years of available data (2012 to 2025), DarioHealth Corp.'s Research And Development Expense has grown by 818.6%.
  • Historical annual values: Fiscal year 2025: $13.79 million | Fiscal year 2024: $24.18 million | Fiscal year 2023: $20.25 million | Fiscal year 2022: $19.65 million | Fiscal year 2021: $17.22 million | Fiscal year 2020: $4.43 million | Fiscal year 2019: $3.69 million | Fiscal year 2018: $3.68 million | Fiscal year 2017: $3.30 million | Fiscal year 2016: $2.15 million | Fiscal year 2015: $2.57 million | Fiscal year 2014: $3.94 million | Fiscal year 2013: $4.91 million | Fiscal year 2012: $1.50 million.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: